Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy
- PMID: 20083197
- DOI: 10.1016/j.ejpb.2010.01.008
Development of microemulsions to topically deliver 5-aminolevulinic acid in photodynamic therapy
Abstract
The aim of this study was to obtain and to characterize microemulsions containing 5-aminolevulinic acid (5-ALA) and to investigate the influence of these systems in drug skin permeation for further topical photodynamic therapy (PDT). 5-ALA was incorporated in water-in-oil (W/O), bicontinuous (Bc), and oil-in-water (O/W) microemulsions obtained by the titration of ethyl oleate and PEG-8 caprylic/capric glycerides:polyglyceryl-6 dioleate (3:1) mixtures with water. Selected systems were characterized by conductivity, viscosity, size of the droplets, and drug release. The stability of the drug in the microemulsions was also assessed. Moreover, the in vitro and in vivo skin permeation of 5-ALA was investigated using diffusion cells and confocal scanning laser microscopy (CSLM), respectively. Despite the fact that the O/W microemulsion decreased the 5-ALA diffusion coefficient and retarded the drug release, it also significantly increased the in vitro drug skin permeation when compared to other 5-ALA carriers. It was observed by CSLM that the red fluorescence of the skin increased homogeneously in the deeper skin layers when the 5-ALA microemulsion was applied in vivo, probably due to the formation of the photoactive protoporphyrin IX. The microemulsion developed carried 5-ALA to the deeper skin layers, increasing the red fluorescence of the skin and indicating the potentiality of the system for topical 5-ALA-PDT.
Similar articles
-
A vehicle for photodynamic therapy of skin cancer: influence of dimethylsulphoxide on 5-aminolevulinic acid in vitro cutaneous permeation and in vivo protoporphyrin IX accumulation determined by confocal microscopy.J Control Release. 2000 Apr 3;65(3):359-66. doi: 10.1016/s0168-3659(99)00213-8. J Control Release. 2000. PMID: 10699294 Clinical Trial.
-
Aminolevulinic acid-loaded Witepsol microparticles manufactured using a spray congealing procedure: implications for topical photodynamic therapy.J Pharm Pharmacol. 2009 Sep;61(9):1125-35. doi: 10.1211/jpp/61.09.0001. J Pharm Pharmacol. 2009. PMID: 19703361
-
The influence of cosurfactants and oils on the formation of pharmaceutical microemulsions based on PEG-8 caprylic/capric glycerides.Int J Pharm. 2008 Mar 20;352(1-2):231-9. doi: 10.1016/j.ijpharm.2007.10.041. Epub 2007 Nov 4. Int J Pharm. 2008. PMID: 18068919
-
Drug delivery of aminolevulinic acid from topical formulations intended for photodynamic therapy.Photochem Photobiol. 2005 Jul-Aug;81(4):750-67. doi: 10.1562/2004-08-23-IR-283. Photochem Photobiol. 2005. PMID: 15790300 Review.
-
Large surface photodynamic therapy with aminolevulinic acid: treatment of actinic keratoses and beyond.J Drugs Dermatol. 2004 Jan-Feb;3(1 Suppl):S26-31. J Drugs Dermatol. 2004. PMID: 14964758 Review.
Cited by
-
Nanoemulsion as a Platform for Iontophoretic Delivery of Lipophilic Drugs in Skin Tumors.Pharmaceutics. 2018 Nov 4;10(4):214. doi: 10.3390/pharmaceutics10040214. Pharmaceutics. 2018. PMID: 30400343 Free PMC article.
-
Development and evaluation of new microemulsion-based hydrogel formulations for topical delivery of fluconazole.AAPS PharmSciTech. 2015 Aug;16(4):889-904. doi: 10.1208/s12249-014-0275-8. Epub 2015 Jan 16. AAPS PharmSciTech. 2015. PMID: 25591952 Free PMC article.
-
Design and characterization of microemulsion systems for naproxen.Adv Pharm Bull. 2013;3(1):63-71. doi: 10.5681/apb.2013.011. Epub 2013 Feb 7. Adv Pharm Bull. 2013. PMID: 24312814 Free PMC article.
-
Treating cutaneous squamous cell carcinoma using 5-aminolevulinic acid polylactic-co-glycolic acid nanoparticle-mediated photodynamic therapy in a mouse model.Int J Nanomedicine. 2015 Jan 6;10:347-55. doi: 10.2147/IJN.S71245. eCollection 2015. Int J Nanomedicine. 2015. PMID: 25609949 Free PMC article.
-
Impact of different vehicles for laser-assisted drug permeation via skin: full-surface versus fractional ablation.Pharm Res. 2014 Feb;31(2):382-93. doi: 10.1007/s11095-013-1167-4. Pharm Res. 2014. PMID: 24022680
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources